Story perspectives

Kennedy Orders HHS to Halt FDA Peptide Enforcement

By Drooid · Oct 29, 2026 · How we work

Read the story

Story summary

Summary

U.S. Secretary Robert F. Kennedy Jr. ordered HHS to tell the FDA not to enforce pharmacy peptide rules.
Most FDA scientific staff opposed the plan, warning it could undermine the agency’s mission to block unproven drugs.
The policy exempts six peptides—BPC-157, TB-500, KPV—while requiring FDA-registered ingredient sources and side-effect reporting.
Kennedy said pharmacies must sell them because Americans would otherwise use gray-market Chinese products.

1 of 1

U.S. Secretary Robert F. Kennedy Jr. ordered HHS to tell the FDA not to enforce pharmacy peptide rules.
Most FDA scientific staff opposed the plan, warning it could undermine the agency’s mission to block unproven drugs.
The policy exempts six peptides—BPC-157, TB-500, KPV—while requiring FDA-registered ingredient sources and side-effect reporting.
Kennedy said pharmacies must sell them because Americans would otherwise use gray-market Chinese products.